Citigroup reiterated coverage on Altria with a new price target
$MO
Medicinal Chemicals and Botanical Products
Health Care
Citigroup reiterated coverage of Altria with a rating of Neutral and set a new price target of $48.00 from $44.50 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/1/2025 | Buy → Hold | Deutsche Bank | |
| 1/16/2025 | $54.00 | Equal-Weight | Morgan Stanley |
| 12/6/2024 | $55.00 → $65.00 | Neutral → Buy | BofA Securities |
| 10/8/2024 | $44.50 → $48.00 | Neutral | Citigroup |
| 1/23/2024 | Sell | UBS | |
| 4/14/2023 | $52.00 | Buy | Stifel |
| 11/10/2022 | $38.00 | Neutral → Sell | UBS |
| 6/29/2022 | $53.00 → $36.00 | Equal Weight → Underweight | Barclays |